Fospropofol Intravenous and Insulin aspart, recombinant Subcutaneous
Determining the interaction of Fospropofol Intravenous and Insulin aspart, recombinant Subcutaneous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: fospropofol
Brand name:
Synonyms: Fospropofol (Intravenous)
Generic Name: insulin aspart
Brand name: Fiasp, NovoLog, NovoLog FlexPen, NovoLog PenFill, NovoLOG FlexTouch, Fiasp PenFill, Fiasp FlexTouch
Synonyms: Insulin aspart, Insulin Aspart
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Fospropofol Intravenous-Insulin degludec
- Fospropofol Intravenous-Insulin Degludec (U-100) Prefilled Pens
- Fospropofol Intravenous-Insulin Degludec (U-100) Vials
- Fospropofol Intravenous-Insulin Degludec (U-200) Prefilled Pens
- Fospropofol Intravenous-Insulin degludec and liraglutide
- Fospropofol Intravenous-Insulin degludec and liraglutide Subcutaneous
- Insulin aspart, recombinant Subcutaneous-Fosrenol
- Insulin aspart, recombinant Subcutaneous-Fosrenol (Lanthanum Chewable Tablets)
- Insulin aspart, recombinant Subcutaneous-Fosrenol (Lanthanum Powder)
- Insulin aspart, recombinant Subcutaneous-Fostamatinib
- Insulin aspart, recombinant Subcutaneous-Fostamatinib disodium
- Insulin aspart, recombinant Subcutaneous-Fosteum